Clinical Trial Update: A Pilot Study Investigating the Effects of Acetyl-L-Carnitine and Vincristine-Induced Neuropathy in Pediatric Patients With ALL [Phase 2]

View source ↗

Summary

Phase 2 pilot trial in pediatric acute lymphoblastic leukemia evaluating acetyl-L-carnitine to mitigate vincristine-induced neuropathy; the study was terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)
• Vincristine (vincristine)

Snippet

Sponsor: Indiana University | Conditions: Vincristine Induced Neuropathy | Phase 2 | Status: TERMINATED | Results posted: 2016-04-28